Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s […]
Vancouver, BC –– Contextual Genomics, developers of genomics-based cancer tests, and the Personalized Medicine Initiative (PMI), an organization bringing molecular-based medicine to Canadians, are pleased to announce global sequencing technology leader, Illumina, Inc. has joined its National Access Project consortium. The National Access Project aims to make genomics testing a standard practice in cancer care […]
CARLSBAD, Calif. — Thermo Fisher ScientificThrough a successful partnership with the Special Bacteriology Reference Laboratory at the Centers for Disease Control and Prevention (CDC), Thermo Fisher Scientific has developed an advanced software solution that enables global public health laboratories to directly access the CDC’s MicrobeNet online virtual reference lab database. Now, researchers can more quickly […]
MOUNTAIN VIEW, Calif.– DNAnexus, the global leader in genome informatics and data management, today announced that it has worked with Intel Corporation, the world’s largest semiconductor company, to deploy elPrep, a high-performance software tool for the preparation of genomic data for large-scale sequence analysis. The first use is by Janssen Research & Development, a division […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the launch of Illumina SeqLab, an integrated solution for customers with HiSeq XTM Systems to enable large-scale human whole-genome sequencing operations. Designed to increase laboratory efficiency for population-scale, human whole-genome sequencing (HWGS), this new offering provides a complete solution for Illumina customers who need streamlined workflows […]
Marietta, GA – Medtown Ventures, LLC (“Medtown”), a venture development firm that specializes in the capitalization and commercialization of promising life science companies today announced that it has entered into an exclusive license agreement with Georgia Tech Research Corporation for a new adhesive-signature based stem cell selection and isolation technology. To focus on the commercialization […]
CARLSBAD, Calif. — Geneuity, a leader in the integration of molecular diagnostics and pathology testing for pharma, contract research organizations, and medical device companies, today announced that it is expanding early access to Thermo Fisher Scientific’s targeted, next-generation sequencing (NGS) technology and Oncomine Focus Assay for services it plans to offer to its broad pharmaceutical […]
LGC is pleased to announce that it has been awarded the role of Coordinator for the new Virtual Food Authenticity Network. This is a Defra initiative to help bring together those involved in food authenticity testing and ensure better collaboration and data sharing between all those with an interest. Ultimately, it will give consumers greater […]
Molecular genetics Ag Biotech company KeyGene and biomedical big data solutions company GENALICE, jointly mark the significant mutual benefits of their first two years of partnership, running GENALICE MAP in full production as their preferred tool for primary (Next-Generation Sequencing (NGS) data analysis. KeyGene supports its customers and partners with cutting edge breeding technologies and […]
GAITHERSBURG, Md. — OpGen, Inc. (Nasdaq:OPGN), has agreed to acquire AdvanDx, Inc., a Woburn, Mass. developer of advanced molecular diagnostic products. The acquisition will be accounted for as a merger combination. The consummation of the merger provides OpGen with a family of FDA approved and CE marked rapid molecular tests for use with the company’s […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
